University of Pennsylvania Law School

Norwegian Cruise Line Holdings Ltd. Appoints José E. Cil to Board of Directors

Retrieved on: 
Tuesday, October 10, 2023

MIAMI, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) (together with NCL Corporation Ltd., "Norwegian Cruise Line Holdings," "Norwegian", “NCLH” or the "Company") today announced the appointment of José E. Cil to its Board of Directors (the "Board") as a new independent director, effective October 6, 2023.

Key Points: 
  • MIAMI, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) (together with NCL Corporation Ltd., "Norwegian Cruise Line Holdings," "Norwegian", “NCLH” or the "Company") today announced the appointment of José E. Cil to its Board of Directors (the "Board") as a new independent director, effective October 6, 2023.
  • With Mr. Cil’s appointment, the Board has expanded from eight to nine members, seven of whom are independent.
  • Mr. Cil will serve as a member of the Company’s Audit Committee.
  • “We are pleased to welcome a highly experienced executive of José’s caliber to our Board,” said Russell W. Galbut, chairman of the Board.

Berger Montague Expands Its Premier Antitrust Practice with Addition of Two Attorneys

Retrieved on: 
Thursday, September 28, 2023

PHILADELPHIA, Sept. 28, 2023 /PRNewswire/ -- Complex litigation powerhouse Berger Montague is pleased to announce that the firm has bolstered its antitrust practice with the addition of Zachary Caplan as a Shareholder and Grace Ann Brew as an Associate. Both new additions will work out of the firm's Philadelphia headquarters.

Key Points: 
  • PHILADELPHIA, Sept. 28, 2023 /PRNewswire/ -- Complex litigation powerhouse Berger Montague is pleased to announce that the firm has bolstered its antitrust practice with the addition of Zachary Caplan as a Shareholder and Grace Ann Brew as an Associate.
  • In the last year alone, the firm has added more than a dozen attorneys and opened three new offices.
  • Mr. Caplan returns to Berger Montague following a year and a half of service with the Antitrust Division of the U.S. Department of Justice.
  • The addition of Zach and Grace Ann is further evidence that Berger Montague is succeeding in creating an environment where thoughtful, creative, aggressive, and diligent attorneys seek to practice."

AIG Appoints Ed Dandridge as Executive Vice President and Chief Marketing & Communications Officer

Retrieved on: 
Thursday, September 21, 2023

American International Group (NYSE: AIG) today announced that Edward L. Dandridge has joined the company as Executive Vice President and Chief Marketing & Communications Officer, effective October 16, 2023.

Key Points: 
  • American International Group (NYSE: AIG) today announced that Edward L. Dandridge has joined the company as Executive Vice President and Chief Marketing & Communications Officer, effective October 16, 2023.
  • Mr. Dandridge will report to Peter Zaffino, Chairman & Chief Executive Officer, and serve on AIG’s Executive Leadership Team.
  • Ed’s previous leadership roles include SVP, Chief Communications Officer of Boeing, Chief Marketing & Communications Officer of Marsh & McLennan, and President & CEO of the National Association of Investment Companies.
  • Mr. Dandridge holds a Bachelor of Arts from Tufts University, with honors, and a Juris Doctor from the University of Pennsylvania Law School.

Ross Kirschner Joins Mitra Chem As General Counsel

Retrieved on: 
Monday, September 11, 2023

MOUNTAIN VIEW, Calif., Sept. 11, 2023 /PRNewswire/ -- Mitra Future Technologies, Inc. ("Mitra Chem"), a leading innovator in North American production of lithium-ion battery materials, today announced Ross Kirschner as General Counsel.

Key Points: 
  • MOUNTAIN VIEW, Calif., Sept. 11, 2023 /PRNewswire/ -- Mitra Future Technologies, Inc. ("Mitra Chem"), a leading innovator in North American production of lithium-ion battery materials, today announced Ross Kirschner as General Counsel.
  • Ross joins Mitra Chem after a distinguished career in the financial services and technology sectors, government, and private practice, leading global regulatory, litigation, investigations, enforcement, public policy, and strategic response functions.
  • Ross' experience includes working with financial service technology innovators and Meta/Facebook, where he both led the legal department's global special investigations team and oversaw several product policy functions.
  • Ross' legal, regulatory, policy, and strategic business background will be vital to drive Mitra Chem's mission to confront the challenge of climate change head-on through spearheading the production and distribution of essential battery materials in North America," said Mitra Chem CEO and Co-Founder Vivas Kumar.

Milbank Expands Private Equity and M&A Practices with Addition of Derek Winokur and Edward Lemanowicz

Retrieved on: 
Wednesday, July 12, 2023

NEW YORK, July 12, 2023 /PRNewswire/ -- Milbank LLP is pleased to announce the addition of Derek M. Winokur and Edward P. Lemanowicz as partners, further strengthening the firm's private equity and mergers and acquisitions practices.

Key Points: 
  • NEW YORK, July 12, 2023 /PRNewswire/ -- Milbank LLP is pleased to announce the addition of Derek M. Winokur and Edward P. Lemanowicz as partners, further strengthening the firm's private equity and mergers and acquisitions practices.
  • Mr. Winokur joins the firm's Global Corporate Group and Mr. Lemanowicz joins the Global Tax Group both in New York.
  • "Milbank is known for high-quality practices around the world, and we are thrilled to join the firm," said Mr. Winokur.
  • Mr. Winokur and Mr. Lemanowicz most recently were partners at Dechert LLP, where Mr. Winokur was co-head of the firm's private equity practice.

Affimed Announces Addition of Dr. Constanze Ulmer-Eilfort to its Supervisory Board

Retrieved on: 
Thursday, June 22, 2023

HEIDELBERG, Germany, June 22, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the appointment of Dr. Constanze Ulmer-Eilfort to its Supervisory Board.

Key Points: 
  • HEIDELBERG, Germany, June 22, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the appointment of Dr. Constanze Ulmer-Eilfort to its Supervisory Board.
  • “We are delighted to announce the appointment of Dr. Ulmer-Eilfort to our Supervisory Board,” said Dr. Thomas Hecht, Chairman of Affimed’s Supervisory Board.
  • “Constanze brings a wealth of legal expertise and a deep understanding of the biotech and healthcare industries, making her an invaluable addition to our team.
  • Since 2021, Dr. Ulmer-Eilfort has served as member of the supervisory board of Evotec SE, a Hamburg-based, publicly listed drug discovery and development company.

Michele Layne, Director of Los Angeles Regional Office, to Leave SEC

Retrieved on: 
Thursday, June 15, 2023

“I commend Michele for her long dedication to public service here at the SEC, where she rose from a staff attorney in our Division of Enforcement to our Regional Director in Los Angeles,” said SEC Chair Gary Gensler.

Key Points: 
  • “I commend Michele for her long dedication to public service here at the SEC, where she rose from a staff attorney in our Division of Enforcement to our Regional Director in Los Angeles,” said SEC Chair Gary Gensler.
  • She became Associate Regional Director for Enforcement in the Los Angeles office in 2005 before being promoted to Regional Director in 2012.
  • Ms. Zoladz has served as Associate Regional Director for Enforcement in the Los Angeles Regional Office since 2019.
  • She joined the Enforcement Division’s Asset Management Unit in 2017 and later became Assistant Regional Director in Los Angeles.

Report From FINRA Board of Governors Meeting – May 2023

Retrieved on: 
Thursday, May 25, 2023

FINRA’s Board of Governors met on May 17-18 for the second time in 2023.

Key Points: 
  • FINRA’s Board of Governors met on May 17-18 for the second time in 2023.
  • During the meeting, the Board appointed a new public governor, approved FINRA’s 2022 Annual Financial Report and added new members to Advisory Committees.
  • Her research and scholarly interests include matters related to corporate and board governance, board fiduciary duties, board-shareholder engagement, board composition and diversity, board oversight, shareholder engagement and activism, affinity fraud, and securities fraud.
  • The next FINRA Board of Governors meeting is scheduled for July.

Manatt Deepens Home-Based and Long-Term Care Capabilities With Prominent Health Leader in D.C.

Retrieved on: 
Thursday, May 4, 2023

“Innovation is a critical part of enhancing the health care delivery system, something Edo has brought to bear through his in-depth knowledge of health care law and policy across the industry,” said Donna L. Wilson , CEO and Managing Partner of Manatt.

Key Points: 
  • “Innovation is a critical part of enhancing the health care delivery system, something Edo has brought to bear through his in-depth knowledge of health care law and policy across the industry,” said Donna L. Wilson , CEO and Managing Partner of Manatt.
  • He advises on a variety of federal and state regulatory matters, including the Health Insurance Portability and Accountability Act (HIPAA), fraud and abuse, administrative appeals, privacy and consent, and state licensing issues.
  • He also counsels clients on Medicare-Medicaid program integrity and overlap as well as on coordinating Medicaid home health partnerships.
  • “Over the years, Edo has worked with a wide range of health care stakeholders—ranging from payers and providers to states and academic medical centers—across government and law, building a thorough understanding of the complex long-term care landscape through various perspectives,” said Manatt Health Leader Bill Bernstein .

LATHAM & WATKINS EXPANDS M&A PRACTICE IN NEW YORK

Retrieved on: 
Monday, March 6, 2023

NEW YORK, March 6, 2023 /PRNewswire/ -- Latham & Watkins LLP1 is pleased to announce that Ian Nussbaum has joined the firm's New York office as a partner in the Mergers & Acquisitions Practice. Nussbaum advises public and private companies on mergers, acquisitions, divestitures, joint ventures, corporate governance, and shareholder activism and takeover defense matters.

Key Points: 
  • NEW YORK, March 6, 2023 /PRNewswire/ -- Latham & Watkins LLP1 is pleased to announce that Ian Nussbaum has joined the firm's New York office as a partner in the Mergers & Acquisitions Practice.
  • "Ian is a top-notch M&A lawyer and we are excited to welcome him to our New York office and the firm," said Marc Jaffe, Office Managing Partner of Latham & Watkins in New York.
  • "Ian's practice complements the breadth and sophistication of services that our extensive, ever-growing base of public company clients require," said Justin Hamill, Global Co-Chair of Latham & Watkins' Mergers & Acquisitions Practice.
  • Prior to entering private practice, Nussbaum served as a law clerk for the Honorable Chancellor Leo E. Strine, Jr. of the Delaware Court of Chancery.